AbbVie is using innovative technologies like AI, wearables and automation to speed up drug discovery, clinical trials, and ...

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform.

"At Neomorph, we have spent years building a unique molecular glue platform ... "We are thrilled to partner with AbbVie, a global leader in delivering transformative medicines in oncology and ...

Collaboration leverages AbbVie's expertise in oncology and immunology ... "At Neomorph, we have spent years building a unique molecular glue platform with broad coverage of the proteome," said ...